Health Technology Assessment of Belimumab: A New Monoclonal Antibody for the Treatment of Systemic Lupus Erythematosus

Objective. Systemic lupus erythematosus (SLE) is treated with anti-inflammatory and immunosuppressive drugs and off-label biologics. Belimumab is the first biologic approved after 50 years as an add-on therapy for active disease. This paper summarizes a health technology assessment performed in Ital...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Specchia, Maria Lucia, de Waure, Chiara, Gualano, Maria Rosaria, Doria, Andrea, Turchetti, Giuseppe, Pippo, Lara, Di Nardo, Francesco, Capizzi, Silvio, Cadeddu, Chiara, Kheiraoui, Flavia, Iaccarino, Luca, Pierotti, Francesca, Palla, Ilaria, Veneziano, Maria Assunta, Gliubizzi, Daniela, Sferrazza, Antonella, Nicolotti, Nicola, Porcasi, Rolando, La Torre, Giuseppe, Di Pietro, Maria Luisa, Ricciardi, Walter
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi Publishing Corporation 2014
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4150460/
https://ncbi.nlm.nih.gov/pubmed/25243173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/704207
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg